ESPR icon

Esperion Therapeutics
ESPR

Overview Fund Activity

150 hedge funds and large institutions have $1.21B invested in Esperion Therapeutics in 2017 Q3 according to their latest regulatory filings, with 33 funds opening new positions, 54 increasing their positions, 45 reducing their positions, and 13 closing their positions.

Holders
150
Holders Change
+19
Holders Change %
+14.5%
% of All Funds
3.75%
Holding in Top 10
6
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-14.29%
% of All Funds
0.15%
New
33
Increased
54
Reduced
45
Closed
13
Calls
$23M
Puts
$42.8M
Net Calls
-$19.8M
Net Calls Change
+$53.8M

Top Buyers

1
MG
1
Meditor Group
Bermuda
$115M
2
BB
2
BB Biotech
Switzerland
$105M
3
PHS
3
PFM Health Sciences
California
$27.5M
4
PCM
4
Pentwater Capital Management
Florida
$112M
5
Caisse de Depot et Placement du Quebec (CDPQ)
5
Caisse de Depot et Placement du Quebec (CDPQ)
Quebec, Canada
$12.6M

Top Sellers

1
RCM
1
RA Capital Management
Massachusetts
$0
2
BC
2
Boxer Capital
California
$25.1M
3
State Street
3
State Street
Massachusetts
$63.2M
4
PC
4
Paulson & Co
New York
$0
5
DCM
5
Discovery Capital Management
Connecticut
$39.2M
Name Market Value Shares Shares
Change 		Shares
Change %
AAMU
26
Amundi Asset Management US
Massachusetts
$9.52M 189,899 +189,899 New
MSE
27
MUFG Securities EMEA
United Kingdom
$9.02M 180,000 +180,000 New
Geode Capital Management
28
Geode Capital Management
Massachusetts
$8.85M 176,611 +34,736 +24%
Invesco
29
Invesco
Georgia
$8.73M 174,097 -118,820 -41%
Credit Agricole
30
Credit Agricole
France
$7.91M 157,900 +157,900 New
IHM
31
Iguana Healthcare Management
New York
$7.52M 150,000 +50,000 +50%
TA
32
Teachers Advisors
New York
$7.17M 142,981 +498 +0.3%
QIM
33
Quantitative Investment Management
Virginia
$6.19M 123,600 +42,800 +53%
Deutsche Bank
34
Deutsche Bank
Germany
$5.91M 117,987 -49,885 -30%
Bank of New York Mellon
35
Bank of New York Mellon
New York
$5.78M 115,372 +519 +0.5%
UBS Group
36
UBS Group
Switzerland
$5.22M 104,191 -47,870 -31%
AQR Capital Management
37
AQR Capital Management
Connecticut
$5.2M 103,726 +74,319 +253%
EI
38
EAM Investors
California
$4.66M 92,899 -7,271 -7%
Charles Schwab
39
Charles Schwab
California
$4.6M 91,843 +23,568 +35%
Voloridge Investment Management
40
Voloridge Investment Management
Florida
$4.59M 91,480 -9,839 -10%
Dimensional Fund Advisors
41
Dimensional Fund Advisors
Texas
$4.55M 90,750 -17,923 -16%
SM
42
Sabby Management
Florida
$4.18M 83,357 +83,357 New
CS
43
Candriam SCA
Luxembourg
$4.01M 80,000 +10,000 +14%
T. Rowe Price Associates
44
T. Rowe Price Associates
Maryland
$3.93M 78,364 -3,183 -4%
B
45
Bailard
California
$3.17M 63,300 – –
JPMorgan Chase & Co
46
JPMorgan Chase & Co
New York
$3.09M 61,800 -107,000 -63%
Citadel Advisors
47
Citadel Advisors
Florida
$2.92M 58,332 +58,332 New
GC
48
Guggenheim Capital
Illinois
$2.76M 55,095 +3,428 +7%
CCI
49
Columbus Circle Investors
$2.61M 51,997 +51,997 New
PPA
50
Parametric Portfolio Associates
Washington
$2.47M 49,335 -813 -2%
1
2
3 4 5